Transaction | Jotup

Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 23 May 2024

Retrieved on:

Tuesday, April 23, 2024

Annual, Cancer, International, Partner, Liver disease, EUR, Brussels Stock Exchange, Convertible, European, Overload, Transaction, Committee, Annual report, Heart failure, Security (finance)

Ghent, Belgium – 23 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today invites the holders of securities issued by the Company to attend the Annual and Extraordinary General Meetings of Shareholders on Thursday, 23 May 2024.

Key Points:

Ghent, Belgium – 23 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today invites the holders of securities issued by the Company to attend the Annual and Extraordinary General Meetings of Shareholders on Thursday, 23 May 2024.
The annual report for the financial year 2023 has been published on Sequana Medical's website and can be accessed here .
The Annual and Extraordinary General Meetings of Shareholders will take place at the Company's registered offices in Ghent and will start at 09:00 am CET.
The Company recommends the holders of its securities to use e-mail for all communications with the Company regarding the Annual and Extraordinary General Meetings of Shareholders.

Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 23 May 2024

Retrieved on:

Tuesday, April 23, 2024

Annual, Cancer, International, Partner, Liver disease, EUR, Brussels Stock Exchange, Convertible, European, Overload, Transaction, Committee, Annual report, Heart failure, Security (finance)

Ghent, Belgium – 23 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today invites the holders of securities issued by the Company to attend the Annual and Extraordinary General Meetings of Shareholders on Thursday, 23 May 2024.

Key Points:

Ghent, Belgium – 23 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today invites the holders of securities issued by the Company to attend the Annual and Extraordinary General Meetings of Shareholders on Thursday, 23 May 2024.
The annual report for the financial year 2023 has been published on Sequana Medical's website and can be accessed here .
The Annual and Extraordinary General Meetings of Shareholders will take place at the Company's registered offices in Ghent and will start at 09:00 am CET.
The Company recommends the holders of its securities to use e-mail for all communications with the Company regarding the Annual and Extraordinary General Meetings of Shareholders.

Sequana Medical announces Annual General Meeting of Shareholders on 25 May 2023

Retrieved on:

Tuesday, April 23, 2024

Annual, Cancer, International, Partner, Liver disease, EUR, Brussels Stock Exchange, Convertible, European, Overload, Transaction, Committee, Annual report, Heart failure, Security (finance)

The annual report for the financial year 2023 has been published on Sequana Medical's website and can be accessed here .

Key Points:

The annual report for the financial year 2023 has been published on Sequana Medical's website and can be accessed here .
The Annual and Extraordinary General Meetings of Shareholders will take place at the Company's registered offices in Ghent and will start at 09:00 am CET.
The full convening notice with the agenda and proposed resolutions can be accessed on the Sequana Medical website: www.sequanamedical.com/investors/shareholder-information .
The Company recommends the holders of its securities to use e-mail for all communications with the Company regarding the Annual and Extraordinary General Meetings of Shareholders.

NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with European Wellness Investment Holdings

Retrieved on:

Monday, April 22, 2024

Transaction, Acquisition, New Generation Pictures, Term sheet, Fertility, Growth

BANGKOK, Thailand, April 22, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced the execution of a non-binding term sheet (the "Term Sheet") regarding a proposed reverse merger (the “Proposed Transaction”) with healthcare company European Wellness Investment Holdings Limited ("EWIHL").

Key Points:

BANGKOK, Thailand, April 22, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced the execution of a non-binding term sheet (the "Term Sheet") regarding a proposed reverse merger (the “Proposed Transaction”) with healthcare company European Wellness Investment Holdings Limited ("EWIHL").
Mr. Siu Wing Fung Alfred, Founder, Chairman, and CEO of NewGen commented, “I am thrilled to announce the signing of a non-binding term sheet with EWIHL, a leading healthcare company.
The proposed reverse merger will bolster our position in several key ways.
Following stockholder approval of the Proposed Transaction, EWIHL Shareholders are expected to hold approximately 76.4% equity interest in NewGen.

G Mining Ventures and Reunion Gold Announce Combination to Set the Stage for a Leading Intermediate Gold Producer in the Americas

Retrieved on:

Monday, April 22, 2024

BROSSARD and LONGUEUIL, Quebec, April 22, 2024 (GLOBE NEWSWIRE) -- G Mining Ventures Corp. (“GMIN”) (TSX: GMIN) (OTCQX: GMINF) and Reunion Gold Corporation (“RGD”) (TSXV:RGD) (OTCQX:RGDFF) are pleased to announce they have entered into a definitive agreement (the “Agreement”) to combine the two companies, setting the stage for the creation of a leading intermediate gold producer (the “Transaction”).

Key Points:

The Transaction sets the stage for the creation of an Americas focused leading intermediate gold producer.
Continues GMIN’s strategy of building an Americas focused intermediate gold producer through its Buy, Build, Operate Strategy.
Strengthens portfolio and positions GMIN to execute on its strategy of building the next intermediate gold producer leading to further re-rate potential and index inclusion.
43% ownership in an emerging intermediate gold producer, with a strong track-record of value creation and share price outperformance.

Titan Provides Update on Planned Merger with Conavi

Retrieved on:

Monday, April 22, 2024

Completion, TMD, TSX, Toronto Stock Exchange, Transaction, TSX Venture Exchange

TORONTO, Ontario, April 22, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to provide this update on its planned merger with Conavi Medical Inc. (“Conavi”) as previously announced on March 18, 2024 (the “Transaction”).

Key Points:

TORONTO, Ontario, April 22, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to provide this update on its planned merger with Conavi Medical Inc. (“Conavi”) as previously announced on March 18, 2024 (the “Transaction”).
As previously announced, Titan has entered into a definitive amalgamation agreement (the “Amalgamation Agreement”) dated March 17, 2024 with Conavi Medical Inc. (“Conavi”) providing for the combination of the companies in an all-stock transaction.
The combined company will focus on continuing to commercialize Conavi’s Novasight Hybrid™ System designed to guide common minimally invasive coronary procedures.
Titan and Conavi continue to work towards the satisfaction of the conditions to completion of the Transaction set forth in the Amalgamation Agreement, including the parties’ work currently underway in respect of the following:
Preparation of submissions to the TSXV in connection with Titan’s planned applications for the listing of its common shares on the TSX Venture Exchange (the “TSXV”) and their delisting from the Toronto Stock Exchange (the “TSX”) and for TSXV approval of the Transaction;
Completion of Titan’s management information circular (the “Titan Circular”) and related documents in connection with Titan’s annual and special meeting at which Titan’s shareholders will be asked to approve the Transaction and other related matters; and
Conavi’s efforts in connection with a concurrent financing of subscription receipts (convertible into Conavi Shares immediately prior to completion of the Transaction), the terms of which will be announced at a later date (the “Concurrent Financing”), for minimum gross proceeds of US$15 million up to a maximum of US$20 million.

AGBA/TRILLER $4 billion MERGER: ELEVATING SHAREHOLDER VALUE TO NEW HEIGHTS - IMMEDIATELY AND FOR THE LONG TERM

Retrieved on:

Friday, April 19, 2024

Mergers and acquisitions, Security (finance), Artificiality, Domestication, 8-K, Transaction, Triller

The Boards of Directors of Triller and AGBA have agreed to value the Combined Group (i.e.

Key Points:

The Boards of Directors of Triller and AGBA have agreed to value the Combined Group (i.e.
AGBA + Triller) at US$4.0 billion.
Triller shareholders (including holders of Triller RSUs) will own 80% of the pro forma Combined Group representing a valuation of US$3,200 million (80% of US$4,000 million).
For more details, please refer to the Company's Report on Form 8-K filed with the Securities and Exchange Commission on 18 April 2024.

Constellation Brands Announces Conversion of Common Shares and Exchange of Promissory Note Into Exchangeable Shares of Canopy Growth Corporation

Retrieved on:

Thursday, April 18, 2024

Constellation, Controlled Substances Act, Indian stock exchange, Sale, Common, Ground substance, Note, Canopy Growth, Amendment, Conversion, Transaction, Constellation Brands, CBG, Security (finance)

VICTOR, N.Y., April 18, 2024 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today that its indirect, wholly-owned subsidiaries, Greenstar Canada Investment Limited Partnership (“Greenstar”) and CBG Holdings LLC (“CBG”), have converted (the "Conversion”) their common shares (“Common Shares”) of Canopy Growth Corporation (“Canopy”) into non-voting and non-participating exchangeable shares of Canopy (“Exchangeable Shares”).

Key Points:

VICTOR, N.Y., April 18, 2024 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today that its indirect, wholly-owned subsidiaries, Greenstar Canada Investment Limited Partnership (“Greenstar”) and CBG Holdings LLC (“CBG”), have converted (the "Conversion”) their common shares (“Common Shares”) of Canopy Growth Corporation (“Canopy”) into non-voting and non-participating exchangeable shares of Canopy (“Exchangeable Shares”).
Greenstar and Canopy also agreed to exchange (the “Note Exchange” and together with the Conversion, the “Transactions”) C$81.2 million of the principal amount of the C$100 million promissory note due December 2024 issued by Canopy (the “Note”) for Exchangeable Shares pursuant to an exchange agreement between Greenstar and Canopy (the “Exchange Agreement”).
For early warning reporting purposes, Constellation will be deemed to beneficially own the Common Shares issuable on conversion of the Exchangeable Shares.
Based on the assumptions noted above and assuming no further issuances of Common Shares or Exchangeable Shares, if Constellation were to convert all such Exchangeable Shares into Common Shares it would hold an aggregate of 26,261,474 Common Shares (representing approximately 26.2% of the currently issued and outstanding Common Shares, inclusive of the as-converted Exchangeable Shares).

Liberty Gold Announces Signing of Definitive Agreement to Sell the TV Tower Project in Türkiye

Retrieved on:

Wednesday, April 17, 2024

Project, Agreement, Sale, LGD, Black pine, OTCQX, TSX, Radio masts and towers, Transaction, Gold, Teahouse

VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (TSX:LGD; OTCQX:LGDTF) (“Liberty Gold” or the “Company”) is pleased to announce it has signed a share purchase agreement (the “Agreement”) for the sale of its interest in the TV Tower copper gold project (“TV Tower” or the “Project”), located in Biga Province, northwest Türkiye, to a foreign mining company.

Key Points:

VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (TSX:LGD; OTCQX:LGDTF) (“Liberty Gold” or the “Company”) is pleased to announce it has signed a share purchase agreement (the “Agreement”) for the sale of its interest in the TV Tower copper gold project (“TV Tower” or the “Project”), located in Biga Province, northwest Türkiye, to a foreign mining company.
Pursuant to the terms of the Agreement, Liberty Gold has agreed to sell its 72.1% interest in the company that holds the Project for gross proceeds to the Company of US$8.3 million in cash, to be paid in three stages over a two-year period (the “Transaction”).
Cal Everett, CEO and Director of Liberty Gold commented, “The sale of TV Tower strengthens Liberty Gold’s treasury position without diluting shareholder’s exposure to our flagship Black Pine project in Southern Idaho while also removing annual carrying costs related to the project.
Liberty Gold will now be 100% Great Basin focused advancing two Carlin-style gold deposits.”
Closing of the Transaction is subject to customary conditions including the approval of the local mining authorities.

McEwen Mining Announces Friendly Acquisition of Timberline Resources

Retrieved on:

Tuesday, April 16, 2024

Agreement, News, Par value, OTCQB, Annual report, Security (finance), TSX, Risk, Acquisition, Transaction, Mining, COVID-19, The Company, MUX

TORONTO, April 16, 2024 (GLOBE NEWSWIRE) -- McEwen Mining Inc. (NYSE: MUX)(TSX: MUX) (“McEwen”) is pleased to announce that it has entered into a definitive agreement and plan of merger (the “Agreement”) to acquire all of the issued and outstanding shares of Timberline Resources Corporation (TSXV:TBR)(OTCQB:TLRS) (“Timberline”) by way of a merger between Timberline and a subsidiary of McEwen (the “Transaction”).

Key Points:

TORONTO, April 16, 2024 (GLOBE NEWSWIRE) -- McEwen Mining Inc. (NYSE: MUX)(TSX: MUX) (“McEwen”) is pleased to announce that it has entered into a definitive agreement and plan of merger (the “Agreement”) to acquire all of the issued and outstanding shares of Timberline Resources Corporation (TSXV:TBR)(OTCQB:TLRS) (“Timberline”) by way of a merger between Timberline and a subsidiary of McEwen (the “Transaction”).
McEwen currently owns 6.25 million Timberline shares representing approximately 3.3% of Timberline’s basic common shares outstanding and 6.25 million Timberline warrants.
Timberline has agreed not to solicit or initiate any discussion regarding any other business combination or acquisition.
In the event that Timberline validly terminates the Agreement to accept a superior offer, Timberline will be required to pay McEwen a termination fee of US$400,000.